PlainPharmaWatch

CMS Open Payments · Program Year 2024

Pajunk Medical Systems, LP

Pajunk Medical Systems, LP reported $4,413.10 across General Payments, Research, and Ownership to 95 physicians and teaching hospitals across 95 transactions.

$4.4K
All-tracks total
95
Transactions
95
Recipients
−$14.4K
General Payments vs PY2023

Pajunk Medical Systems, LP reported $4,413.10 across all CMS Open Payments tracks (General + Research + Ownership) to 95 physicians and teaching hospitals in Program Year 2024 - ranking #1726 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $4,413.10, averaging $46.45 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer pajunk-medical-systems-lp Pajunk Medical Systems, LP

$4.4K · #1726/1,925 · 0.0% industry · PY2024

  • TOT $4.4K
  • RANK #1726
  • SHARE 0.0%
  • TXN 95
  • RCP 95
  • CAT 2
  • GEN $4.4K
  • ΔGEN −$14.4K
  • TOP1 9.9%
  • PY 2024

Nearest volume peer: Vero Biotech Inc. ($4.4K)

VivaQuant Inc, dba Rhythm Ex…$4.5KPajunk Medical Systems, LP (…$4.4KVero Biotech Inc.$4.4KCosa Medical, Llc$4.3KEnsemble Orthopedics, Inc$4.3K
All-tracks payment totals near Pajunk Medical Systems, LP (CMS Open Payments PY2024)

Pajunk Medical Systems, LP sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Pajunk Medical Systems, LP's CMS-reported General Payments decreased by $14.4K (−76.5%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: PAJUNK MEDICAL SYSTEMS, LPPY2023: PAJUNK MEDICAL SYSTEMS, LPPY2024: Pajunk Medical Systems, LP. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$18.8KPY2024$4.4K
PY2023
$18,798.57
PY2024
$4,413.10

What the Data Shows for Pajunk Medical Systems, LP

Pajunk Medical Systems, LP ranks #1726 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $4,413.10 across 95 transactions to 95 physicians and teaching hospitals - $46.45 per transaction and $46.45 per recipient on average.

"Food and Beverage" leads the 2-category general-payment breakdown below at $4.0K (90.1% of General Payments, 94 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Food and Beverage" leads Pajunk Medical Systems, LP's 2-category general-payment breakdown at $4.0K, 90.1% of the reported total.

How Pajunk Medical Systems, LP divides its payments

Ranked by total dollars reported per category

1. Food and Beverage$4.0K2. Consulting Fee$437.50
Payment Type Amount Transactions
Food and Beverage $4.0K 94
Consulting Fee $437.50 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,962.94 (44.5%) of $4,413.10 in this company's General Payments records across 95 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Pajunk Medical Systems, LP

The five named recipients with the highest reported General Payments from this company

William Bullock$437.50Jerry Jones$381.36James Smyth$381.36Eugene Viscusi$381.36Eric Silverman$381.36
  1. 1

    William Bullock

    $437.50 across 1 reported transactions

  2. 2

    Jerry Jones

    $381.36 across 1 reported transactions

  3. 3

    James Smyth

    $381.36 across 1 reported transactions

  4. 4

    Eugene Viscusi

    $381.36 across 1 reported transactions

  5. 5

    Eric Silverman

    $381.36 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Pajunk Medical Systems, LP's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Pajunk Medical Systems, LP.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Pajunk Medical Systems, LP.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Pajunk Medical Systems, LP's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.